Bioavailability enhancement of curcumin by complexation with phosphatidyl choline

Journal of Pharmaceutical Sciences

Volumn 100, Issue 5, 2011, Pages 1987-1995

  Gupta, Nishant Kumar ^a   Dixit, Vinod Kumar ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Absorption; Bioavailability; Calorimetry (DSC); Complexation; Hepatocytes; Hepatoprotective; Pharmacokinetic; Phosphatidyl choline (PC)

Indexed keywords

CURCUMIN; PHOSPHATIDYLCHOLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG SOLUBILITY; DRUG STRUCTURE; FEMALE; INFRARED SPECTROSCOPY; LIPID SOLUBILITY; LIVER CELL; LIVER PROTECTION; MALE; MAXIMUM PLASMA CONCENTRATION; MELTING POINT; NONHUMAN; RAT; THIN LAYER CHROMATOGRAPHY; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 79952238275     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22393     Document Type: Article

References (26)

1. Aggarwal BB, Kumar A, Bharti AC. 2003. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res 23:363-398.
2. Sharma RA, Gescher AJ, Steward WP. 2005. Curcumin: The story so far. Eur J Cancer 41:1955-1968.
3. Tonnesen HH, Masson M, Loftsson T. 2002. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: Solubility, chemical and photochemical stability. Int J Pharm 244:127-135.
4. Pan MH, Huang TM, Lin JK. 1999. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 27:486-494.
5. Johnson JJ, Mukhtar H. 2007. Curcumin for chemoprevention of colon cancer. Cancer Lett 255:170-181.
6. Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, Marczylo TH, Morgan B, Hemingway D, Plummer SM, Pirmohamed M, Gescher AJ, Steward WP. 2004. Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance. Clin Cancer Res 10:6847-6854.
7. Marczylo TH, Verschoyle RD, Cooke DN, Morazzoni P, Steward WP, Gescher AJ. 2007. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidyl choline. Cancer Chemother Pharmacol 60:171-177.
8. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. 2007. Bioavailability of curcumin: Problems and promises. Mol Pharm 4:807-818.
9. Cui J, Yu B, Zhaoe Y, Zhua W, Li H, Lou H, Zhaia G. 2009. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm 371: 148-155.
10. Sharma A, Gupta NK, Dixit VK. 2010. Complexation with phosphatidyl choline as a strategy for absorption enhancement of boswellic acid. Drug Deliv 17:587-95.
11. Bombardelli E, Curri SB, Della LR. 1989. Complexes between phospholipids and vegetal derivatives of biological interest. Fitoterapia 90(Suppl 1):1-9.
12. Yanyu X, Yunmei S, Zhipeng C, Qineng P. 2006. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm 307:77-82.
13. Ying L, Yang DJ, Chen SL, Chen SB, Chan AS. 2008. Comparative physiochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods. Pharm Res 25:563-577.
14. Ravindranath V, Chandrasekhara N. 1981. In vitro studies on the intestinal absorption of curcumin in rats. Toxicology 20:251-257.
15. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. 1998. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64:353-356.
16. Gupta NK, Nahata A, Dixit VK. 2010. Development of a spectrofluorimetric method for the determination of curcumin. Asian J Trad Med 5:51-57.
17. Seglen PO. 1975. Preparation of isolated rat liver cells. Methods Cell Biol 13:29-83.
18. Visen PKS, Shukla B, Patnaik GK, Chandra R, Singh V, Kapoor NK, Dhawan BN. 1991. Hepatoprotective activity of picroliv isolated from Picrorrhiza kurroa against thioacetamide toxicity on rat hepatocytes. Phytother Res 5:224-227.
19. Reitman S, Frankel AS. 1957. A colorimetric method for the determination of serum glutamyl oxalacetic acid glutamyl pyruvate transaminase. Am J Clin Pathol 28:56-58.
20. King EJ, Wootton IDP. 1964. Micro-analysis in medical biochemistry. 4th ed. London: Churchill.
21. Barzaghi N, Crema F, Gatti G. 1990. Pharmacokinetic studies on IdB 1016, a silybinphosphatidyl choline complex, in healthy human subjects. Eur J Drug Metab Pharmacokinet 15:333-338.
22. Buzzelli G, Moscarella S, Giusti A. 1993. A pilot study on the liver protective effect of silybinphosphatidylcholine complex (IdB1016) in chronic active hepatitis. Int J Clin Pharmacol Ther Toxicol 31:456-460.
23. Kumar M, Ahuja M, Sharma SK. 2008. Hepatoprotective study of curcumin-soya lecithin complex. Sci Pharm 76:761-774.
24. Barthe L, Woodley J, Kenworthy S, Houin G. 1998. An improved everted gut sac as a simple and accurate technique to measure para-cellular transport across the small intestine. Eur J Drug Metab Pharmacokinet 23:313-323.
25. Das SK, Vasudevan DM. 2006. Effect of lecithin in the treatment of ethanol mediated free radical induced hepatotoxicity. Indian J Clin Biochem 21:62-69.
26. Raj PV, Nitesh K, Chandrashekhar HR, Rao CM, Rao JV, Udupa N. 2010. Effect of lecithin and silymarin on d-galactosamine induced toxicity in isolated hepatocytes and rats. Indian J Clin Biochem 25:169-174.